UFP Industries (UFPI)
Entry: TBD in Hyper Stocks Pro
Price target: Members Only
UFP Industries is not the flashiest name in the market, but sometimes the best opportunities are found in companies that do boring things at massive scale.
What does UFPI do?
UFPI is a holding company behind UFP Packaging, UFP Construction, and UFP Retail. They take raw lumber and turn it into finished products used across housing, commercial construction, packaging, retail, decking, pallets, prefab framing, and industrial applications.
The company is one of the largest softwood lumber converters in North America and one of the largest pressure treated wood players in the world. That gives them a major scale advantage in sourcing, production, and distribution across three huge end markets: construction, retail, and industrial packaging.
Key UFPI Projects
The business UFPI currently operates in is a cyclical one, but they’re shifting away from pure commodity wood exposure and into higher margin, value added products like composites, branded decking, treated lumber, prefabricated components, pallets, and alternative materials like steel, aluminum, foam, corrugate, and composites. Commodity lumber is cyclical, value added products are where the margins and business durability improve.
Brief Financial Overview
Although recent financials have been weak and YoY revenue has been falling, the company is well set- p for a turnaround as single family housing starts increase (projected to do so into 2027), interest rates come down, and as their expansion into more durable businesses materializes.
UFPI trades at a discount to many industry and peer averages across several valuation metrics. Its forward P/E is around 15.6x compared to a much higher industry average. Its price-to-book and price-to-sales ratios also appear cheaper than the broader group.
It’s important to note that the setup is not immediate, but it is improving. 2026 looks more like a transition year. Housing activity is still challenged, wood products consumption may remain flat, and mortgage rates likely need to move lower before volume really accelerates, but markets rarely ever wait for everything to happen before they start buying. Savvy investors begin buying into future turnaround opportunities before they happen, and now seems to be a good time as we enter the second half of 2026.
Please note that the stock includes risks and price targets are subject to change based on market developments and company updates. These stocks usually take time to come around and the outlook may change. Trade at your own risk.
Select Sector Health Care SPDR ETF (XLV)
Entry: TBD in Hyper Stocks Pro
Price target: Members Only
Something interesting happened last week…as the S&P 500 and Nasdaq 100 posted record single day losses, one of the most prominent healthcare ETFs made a full recovery to its January opening price. Healthcare stocks have lagged far behind the technology rally, but they remain an absolute necessity, making them a great defensive play when there’s a hint of uncertainty.
The recovery of this ETF while technology stocks were selling off is a clear example of how money chases “safety” and quality when fear re-enters the market. But we’re not only looking at this name because it can act as a safe haven, there are other reasons for a bullish case.
U.S. manufacturing reshoring is becoming a major theme across multiple industries, and healthcare may be one of the biggest beneficiaries. Between pharmaceuticals, medical devices, diagnostics, and biotechnology, the U.S. has a growing incentive to bring more production back home. The pandemic exposed how fragile global supply chains can be, especially when it comes to critical drugs, hospital equipment, and medical supplies. That has created a long-term push toward domestic production, stronger supply chains, and more investment in healthcare infrastructure
XLV Holdings
This ETF gives exposure to top healthcare companies like: Eli Lilly, Johnson & Johnson, AbbVie, UnitedHealth Group, Merck, Amgen, Thermo Fisher Scientific, Gilead Sciences, Abbott Laboratories, and Intuitive Surgical.
Technology and Healthcare
The other part of the story is technology. Healthcare is no longer just hospitals, insurance, and drug companies. The industry is becoming tied to artificial intelligence, robotics, automation, diagnostics, data, and personalized medicine…this is definitely one of the biggest angles.
That matters because while investors often think of “technology” as semiconductors, software, and AI infrastructure, healthcare is also applying technology in ways that can create massive long-term value. AI can help accelerate drug discovery. Robotics can improve surgery. Wearables can monitor patients in real time (We just played and covered $DXCM for this!). Diagnostics can catch diseases earlier. Data can help hospitals operate more efficiently.
That gives XLV an interesting setup. It offers exposure to a sector that investors may rotate into when market fear rises, but it also has long-term growth drivers through innovation, aging demographics, reshoring, and technology adoption.
Please note that the stock includes risks and price targets are subject to change based on market developments and company updates. These stocks usually take time to come around and the outlook may change. Trade at your own risk.
You’ve reached the end of our complimentary public watchlist. To unlock the full watchlist, real-time trade updates, entries, exits, and ongoing analysis, upgrade to Hyper Stocks Pro today.
You’ve reached the end of our complimentary public watchlist. To unlock the full watchlist, real-time trade updates, entries, exits, and ongoing analysis, upgrade to Hyper Stocks Pro today.
You’ve reached the end of our complimentary public watchlist. To unlock the full watchlist, real-time trade updates, entries, exits, and ongoing analysis, upgrade to Hyper Stocks Pro today.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult with a licensed financial advisor before making investment decisions.
Hyper Stocks and its contributors may hold positions in some of the securities or assets mentioned above. These positions are subject to change without notice. Any opinions expressed reflect current views at the time of writing and are not guarantees of future performance. Past performance does not guarantee future results.